from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1874/-

LFCtreatmentdescriptionclass of inhibitor

-0.249

Amikacinug/mL Amikacintranslation

0.617

Cap5-10ug/mL Capreomycintranslation

0.279

Rox10-50 ug/mL Roxithromycintranslation

-0.484

SM2-5 ug/mL Streptomycintranslation

0.267

Tet5-10 ug/mL Tetracyclinetranslation

-0.308

Rif0.2-5ug/mL Rifampicintranscription

-0.371

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.296

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.395

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.049

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.307

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.662

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.169

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.543

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.133

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.159

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.103

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.167

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.094

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.693

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.065

KCN5-20 ug/mL Potassium cyaniderespiration

-0.253

NaN30.2-2 mM Sodium aziderespiration

-0.531

Nigericin50 uM Nigericinrespiration

0.171

TRC10-150 ug/mL Triclosanrespiration

0.932

TRZ10-25 ug/mL Thioridazinerespiration

-0.319

Valinomycin0.5-10 uM Valinomycinrespiration

-1.880

ZnSO42 mM ZnSO4respiration

0.557

menadione6-10 ug/mL Menadionerespiration

-0.131

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.640

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.443

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.685

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.073

NRP_1Non-replicating persistence stage 1dosRassociated

-0.286

Amp0.2mg/mL AmpicillincellWall

-0.275

Cephalexin20-100 ug/mL CephalexincellWall

-0.644

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.422

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.302

EMB10-20 ug/mL EthambutolcellWall

-0.829

Eta12-40 ug/mL EthionamidecellWall

-0.850

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.463

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.488

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.725

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.275

BZA0.12 mg/mL BenzamidearomaticAmides

0.318

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.622

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.514

H2O24 mM hydrogen peroxideDNAdamaging

-0.145

Levo10 ug/mL LevofloxacinDNAdamaging

-0.286

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.140

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.201

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.790

UVUV-irradiationDNAdamaging

2.725

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.378

Antimycin12.5-50 ug/mL Antimycin A?

-0.641

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.035

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.143

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.589

PA8240.2-2 ug/mL PA-824?

-0.848

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.601

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.268

Verapamil50 uM Verapamil?

0.064

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.482

methoxatin10-20 ug/mL Methoxatin?